6 employees
Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.
2020
$1.3M
from 2 investors over 2 rounds
CasInvent Pharma raised $1.3M on September 26, 2022
Investors: KHANU Management GmbH and i&i Biotech Fund